The Net Margin of Oncopeptides AB (ONCO.ST) is -899.29%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -899.29% |
| 2023-12-31 | -707.30% |
| 2022-12-31 | -4044.90% |
| 2021-12-31 | -1209.11% |